EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER
Liver Cancer SUMMIT 20215-6 February 2021 Virtual Conference
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| P-001 | Surgery versus Sorafenib in case of BCLC-C hepatocellular carcinoma: an Italian weighted study | Simone Famularo |  Received |
 |
|||
| P-002 | Current Trends of Hepatocellular Carcinoma Characteristics in Greece | Georgios Markakis | Received |
|
|||
| P-004 | Association between serum magnesium concentration and hepatocellular carcinoma in cirrhotic patients | Simona Parisse | Received |
|
|||
| P-005 | The best potential treatment for recurrent hepatocellular carcinoma after surgery: a machine learning predictive model for treatment allocation based on an Italian multicentric database | Francesca Carissimi | Received |
|
|||
| P-009 | Hepatocellular carcinoma prognostic scores: filling the gap? | Michele Campigotto | Received |
|
|||
| P-011 | Increased platelet aggregation in patients with cirrhosis and hepatocellular carcinoma: a new potential therapeutic target? | Alberto Zanetto | Received |
|
|||
| P-013 | chronic hepatitis b under tenofovir or entecavir: performance of the page-b score to predict hepatocellular carcinoma | Daniela Falcão | Received |
|
|||
| P-014 | Diagnosing hepatocellular carcinoma are we getting it right first time? | Emma Saunsbury | Received |
|
|||
| P-018 | Association between postoperative early recurrence of hepatocellular carcinoma and the expression pattern of circulating tumor cells in peripheral blood sample: a preliminary study. | Cristina Ciulli | Received |
|
|||
| P-019 | Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma | Filippo Pelizzaro | Received |
|
|||
| P-021 | Prognostic role of platelets-to lymphocytes ratio (PLR) and neutrophils-to-lymphocytes ratio (NLR) in hepatocellular carcinoma patients | Filippo Pelizzaro | Received |
|
|||
| P-022 | Impact of hospital volume on hepatocellular carcinoma survival in Italy | Filippo Pelizzaro | Received |
|
|||
| P-025 | Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2cm or smaller: a cohort study in Taiwan | Ching-Sheng Hsu | Received |
|
|||
| P-027 | Phenotypic characteristics of the tumour microenvironment in primary and secondary hepatocellular carcinoma. | Petros Fessas | Received |
|
|||
| P-028 | Are undetected stones in the common biliary duct one of the causes of abscesses and bilomas development after percutaneous thermal ablation procedures? | Letizia Veronese | Received |
|
|||
| P-029 | Different modalities in management of bleeding related to post-banding ulcer following endoscopic variceal ligation in cirrhotic patients with or without hepatocellular Carcinoma | Mohamed Abdel-Samiee | Received |
|
|||
| P-032 | NADPH oxidase 4 (Nox4) deletion accelerates liver regeneration in mice | MACARENA HERRANZ ITÚRBIDE | Received |
|
|||
| P-034 | Methylated Septin 9 (mSEPT9) as a biomarker for hepatocellular carcinoma. Results from University Hospital Coventry and Warwickshire NHS Trust, UK | Ayman Bannaga | Received |
|
|||
| P-036 | Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy. | David Pinato | Received |
|
|||
| P-037 | PNPLA3 and Notch3 gene polymorphisms as risk factors for alcoholic cirrhosis development and its progression to hepatocellular carcinoma | Anna Mrzljak | Received |
|
|||
| P-038 | Urinary volatile organic compounds characterization in hepatocellular carcinoma pilot study | Ayman Bannaga | Received |
|
|||
| P-039 | Comparison of incidence and mortality risks due to acute kidney injury in hepatocellular carcinoma patients after liver resection, ablation, and transarterial chemoembolization: Meta-analysis of cohort studies | Boby Pratama Putra | Received |
|
|||
| P-041 | Transarterial chemoembolization: Predictors of liver function deterioration prior to hepatocellular carcinoma refractoriness | Joel Ferreira-Silva | Received |
|
|||
| P-042 | Two birds one stone: a case of synchronous hepatocellular carcinoma and intrahepatic cholangiocarcinoma | Catarina Félix | Received |
|
|||
| P-048 | Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC. A single center retrospective case control study. | Bianca Rocco | Received |
|
|||
| P-049 | Perfusion analysis with dynamic contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma: a pilot study of a novel parameter aiming to improve the detection of wash-out | Lorenzo Mulazzani | Received |
|
|||
| P-054 | Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice: CARDIO-SOR study. | Lorena Carballo-Folgoso | Received |
|
|||
| P-055 | Treatment of the chemotherapy induced hepatotoxicity | Mariia Zharova | Received |
|
|||
| P-057 | Hepatocellular Carcinoma Surveillance in Cirrhotic patients. | Shreyashee Sengupta | Received |
|
|||
| P-059 | Targeting tumor-initiating cells and compensatory YAP pathway activation to overcome sorafenib-induced resistance in hepatocellular carcinoma | Darko Castven | Received |
|
|||
| P-060 | Immunosuppressive Drug Resistant Armored TCR T cells for immune-therapy of HCC in liver transplant patients | Anthony Tan | Received |
|
|||
| P-062 | The impact of ultrasonographic blind spots for detecting early-stage hepatocellular carcinoma during surveillance | HA IL KIM | Received |
|
|||
| P-066 | The combination of alcohol and metabolic syndrome is a fast track to hepatic tumorigenesis | Raquel Benedé-Ubieto | Received |
|
|||
| P-067 | Thyroid disease and hepatocellular carcinoma survival. A Danish nationwide cohort study | Linda Skibsted Kornerup | Received |
|
|||
| P-068 | Usefulness of circulating tumor cells in the management of patients with hepatocellular carcinoma | Elena Vargas Accarino | Received |
|
|||
| P-069 | Prognostic value of metabolic imaging data of C-choline PET/CT in patients undergoing hepatectomy for hepatocellular carcinoma | Jacopo Galvanin | Received |
|
|||
| P-071 | Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells | Alessandra Gentilini | Received |
|
|||
| P-075 | Tumor Burden Score: a novel tool to predict immune-related liver injury during immunotherapy for hepatocellular carcinoma | Antonio DAlessio | Received |
|
|||
| P-076 | Phase 3 KEYNOTE-937 Trial: Adjuvant Pembrolizumab for Hepatocellular Carcinoma and Complete Radiologic Response After Surgical Resection or Local Ablation | Arndt Vogel | Received |
|
|||
| P-077 | PRPF8 regulates FAK/AKT pathway via fibronectin 1 splicing modulation to promote hepatocellular carcinoma aggressiveness | Juan Luis López-Cánovas | Received |
|
|||
| P-078 | Retrospective analysis of one-center experience in diagnosis and treatment of liver cancer | Mariia Zharova | Received |
|
|||
| P-079 | Analysis of risk factors associated with hepatocellular carcinoma development in patients with hepatitis B virus infection | Christos Triantos | Received |
|
|||
| P-081 | Validation of the aMAP risk score for the development of hepatocellular cancer in patients with cirrhosis in Glasgow | Chris Curran | Received |
|
|||
| P-082 | In vivo quantification of micro-balloon interventions (MBI) advantage. Cohort, retrospective, bi-centric study of DEB-TACE vs b-TACE and SIRT vs b-SIRT | Claudio Trobiani | Received |
|
|||
| P-083 | Comparison of Liver Transplant Criteria for Hepatocellular Carcinoma | Volkan &304;nce | Received |
|
|||
| P-085 | DNA Methyltransferases as Potential Biomarkers for Egyptian Patients with HCV Related Hepatocellular Carcinoma | Mohamed Abdel-Samiee | Received |
|
|||
| P-086 | Survival analysis of the most frequent Single Nucleotide Variants in Hepatocellular Carcinoma | Jimmy A. Daza Barragan | Received |
|
|||
| P-087 | Se and Zn supplements attenuates HCC among recovered Hepatitis C Obese population in Middle Belt Nigeria. | OLAJUYIN OLALEYE | Received |
|
|||
| P-088 | CAMD score predicts the risk of hepatocellular carcinoma in Tunisian patients with chronic hepatitis B on antiviral therapy | Myriam Ayari | Received |
|
|||
| P-091 | Real-world experience of hepatocellular carcinoma patients after sorafenib treatment: eligibility to subsequent lines and prognostic factors. | Leonardo Gomes da Fonseca | Received |
|
|||
| P-094 | Pattern of macrovascular invasion in patients with hepatocellular carcinoma influences treatment and outcome. | Maria Guarino | Received |
|
|||
| P-098 | Prediction of early recurrence of hepatocellular carcinoma after resection: international validation of the ERASL risk models | Berend Beumer | Received |
|
|||
| P-101 | Is first- and second-line immunotherapy sequence the optimal strategy for unresectable hepatocellular carcinoma? | Ciro Celsa | Received |
|
|||
| P-102 | Circulating miR 373 but not miR 210 as a new promising preoperative predictor of response to superive transarterial chemoembolization bridging therapy in Egyptian patients with hepatocellular carcinoma on top of hepatitis C virus infection | Omneya AbdelKarem | Received |
|
|||
| P-103 | Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients | Berend Beumer | Received |
|
|||
| P-107 | lncRNA-H19 as a marker of liver disease progression: Hepatocellular Carcinoma | Ángela Rojas | Received |
|
|||
| P-110 | Epidemiological trends of hepatocellular carcinoma in patients with Metabolic-Dysfunction-Associated Fatty Liver Disease (MAFLD) in Italy. | Monica Cucco | Received |
|
|||
| P-112 | Are Radiology-based endpoints robust surrogate outcomes of overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization? | Ciro Celsa | Received |
|
|||
| P-113 | Vimentin expression in hepatocellular carcinoma relates with progenitor cells and epithelial-mesenchymal transition carcinogenesis | Joana Espírito Santo | Received |
|
|||
| P-119 | Modified Page B Score Performance in Predicting HCC Risk in patients with chronic hepatitis B on antiviral therapy. | Fatma Ben Farhat | Received |
|
|||
| P-122 | Prognostic performance of Toronto HCC risk index and the alpha-fetoprotein rate in patients with Hepatocellular carcinoma | Nouha Trad | Received |
|
|||
| P-125 | Performance of ten non-invasive liver function tests in predicting one-year mortality in patients with hepatocellular carcinoma | Nouha Trad | Received |
|
|||
| P-126 | Impact of Hepatocellular Carcinoma screening in patients with Non-Achoholic Fatty Liver Disease and survival analyzis: a Brazilian Cross-Section Study | Regiane Saraiva de Souza Melo Alencar | Received |
|
|||
EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER
Liver Cancer SUMMIT 2021
5-6 February 2021 Virtual Conference
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 11/01/2021 TO 05/02/2022
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
|
|
